CLASS II ONGOING Device recall · Reported 12 Mar 2025 · FDA Enforcement Report

Vios Monitoring System Bedside Monitor recalled by Murata Vios

Murata Vios is recalling Vios Monitoring System Bedside Monitor, distributed nationwide in the US. The recall was initiated on 9 Aug 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes1.56.01 UDI: +B595BSM20500/$$7V1.56.01/16D20230630S 1.57.20 UDI: +B595BSM20500/$$7V1.57.20/16D20231129Y Software Versions 1.56.01 and 1.57.20
Quantity recalled50

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1292-2025
FDA event ID
96252
Recalling firm
Murata Vios, Woodbury, MN
Classification
Class II
Status
Ongoing
Recall initiated
9 Aug 2024
FDA classified
6 Mar 2025
Reported
12 Mar 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons
Device type
Patient Monitors

Timeline

9 Aug 2024Recall initiated by company
6 Mar 2025Classified by FDA+209 days
12 Mar 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Batteries may deplete over time while not in use if devices are stored without being plugged in to wall outlet. Depleted batteries may lead to tablet connectivity issues.

Product as listed by the FDA

Vios Monitoring System Bedside Monitor Model BSM2050

Where it was distributed

US Nationwide distribution in the states of Florida, Louisiana, Maryland, Montana, New York, Ohio, and Texas.

Nationwide FloridaLouisianaMarylandMontanaNew YorkOhioTexas

Questions about this recall

Why was it recalled?

Batteries may deplete over time while not in use if devices are stored without being plugged in to wall outlet. Depleted batteries may lead to tablet connectivity issues.

Which lots are affected?

1.56.01 UDI: +B595BSM20500/$$7V1.56.01/16D20230630S 1.57.20 UDI: +B595BSM20500/$$7V1.57.20/16D20231129Y Software Versions 1.56.01 and 1.57.20

Where was it sold?

US Nationwide distribution in the states of Florida, Louisiana, Maryland, Montana, New York, Ohio, and Texas.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Murata Vios

All 4

Other Patient Monitors recalls

All 1,023